| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/09/2005 | WO2005008248A3 Diagnosis and treatment of cervical cancer |
| 06/09/2005 | WO2005007891A3 Variants of human taste receptor genes |
| 06/09/2005 | WO2005001103A3 Methods of generating chimeric adenoviruses and uses for such chimeric adenoviruses |
| 06/09/2005 | WO2005000403A3 Compositions and methods for treating and preventing heart tissue degeneration, and uses thereof |
| 06/09/2005 | WO2004108756A3 Sars coronavirus peptides and uses thereof |
| 06/09/2005 | WO2004107618A9 Gitr ligand and gitr ligand-related molecules and antibodies and uses thereof |
| 06/09/2005 | WO2004104596A3 Diagnostics and therapeutics for diseases associated with igs70 (igs70) |
| 06/09/2005 | WO2004104220A3 Use of a biotinylated polypeptide for determining the activity of protein-phosphorylating enzymes |
| 06/09/2005 | WO2004104171A3 Ranbp2 as modifier of the pten/igf pathway and methods of use |
| 06/09/2005 | WO2004092336A3 Fragments of fluorescent proteins for protein fragment complementation assays |
| 06/09/2005 | WO2004087730A3 Method for producing diverse libraries of encoded polymers |
| 06/09/2005 | WO2004084939A8 Hiv-peptide-carrier-conjugates |
| 06/09/2005 | WO2004081177A3 Intracellular signaling pathways in diabetic subjects |
| 06/09/2005 | WO2004080403A3 Influenza virus vaccine |
| 06/09/2005 | WO2004045639A8 Live attenuated vaccine against porcine pleuropneumonia |
| 06/09/2005 | WO2004043383A8 A new target for angiogenesis and anti-angiogenesis therapy |
| 06/09/2005 | WO2004039999A3 Essential dna enclosed proteins of drosphophilia melanogaster |
| 06/09/2005 | WO2004035743A8 Site specific incorporation of keto amino acids into proteins |
| 06/09/2005 | WO2004033483A3 Liposomal system and method of using same |
| 06/09/2005 | WO2004000007A3 Methods of modulating cytokinin related processes in a plant using b3 domain proteins |
| 06/09/2005 | WO2003062400A9 Fiber shaft modifications for efficient targeting |
| 06/09/2005 | WO2002048312A3 Backbone cyclized inhibitors of heat shock proteins |
| 06/09/2005 | US20050125859 Modified galactosidase for use as tool in enzyme replacement therapy and treatment of lysosomal storage diseases in humans and animals |
| 06/09/2005 | US20050125855 Enhanced plant cell transformation by addition of host genes involved in T-DNA integration |
| 06/09/2005 | US20050125854 Rice transposon genes |
| 06/09/2005 | US20050125847 Using reporter gene expression to identify transformed/modified insects; biological pest control; insecticides |
| 06/09/2005 | US20050125846 Expression vector comprising nucleotide sequences coding transmembrant transport protein for use in diagnosis, treatment and prevention of thyroid disorders |
| 06/09/2005 | US20050124803 Genetically engineered insecticidal protein for use in controlling mosquito population; biological pest control |
| 06/09/2005 | US20050124802 Novel human membrane proteins and polynucleotides encoding the same |
| 06/09/2005 | US20050124801 Nucleotide sequences coding cell growth factor polypeptides fusions for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 06/09/2005 | US20050124800 Mammalian migration inducting gene and methods for detection and inhibition of migrating tumor cells |
| 06/09/2005 | US20050124797 Production of soluble keratin derivaties |
| 06/09/2005 | US20050124796 Mouse cytokine receptor |
| 06/09/2005 | US20050124795 DNA encoding a human subunit 5-HT3-C of the 5-HT3 serotonin receptor |
| 06/09/2005 | US20050124794 Histidine-proline rich tropomyosin-related anti-angiogenic receptor polypeptide or peptide tor use in prevention and treatment of tumor |
| 06/09/2005 | US20050124793 Novel proteins and dnas thereof |
| 06/09/2005 | US20050124792 Expression vector comprising nucleotide sequences coding G-protein coupled photoreceptor proteins for use in tools in pharmaceutical design; bioreactors and heterologous protein expression |
| 06/09/2005 | US20050124791 Ion channel |
| 06/09/2005 | US20050124790 Protein fusion comprising sequences capable of being cleaved by ubiquitin cleavage enzyme; isolating heterologous expressed, recombinant polypeptide from mixture |
| 06/09/2005 | US20050124789 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/09/2005 | US20050124573 Hepatitis C virus codon optimized non-structural NS3/4A fusion gene |
| 06/09/2005 | US20050124564 Administering vector comprising nucleic acid sequence encoding erythropoietin; controlling gene expression |
| 06/09/2005 | US20050124561 Administering fungicide for mucous membrane; asthma therapy |
| 06/09/2005 | US20050124551 Or its cystine-coupled dimer, mixed with a nonsteroidal antiinflammatory agent used to treat contact dermatitis. |
| 06/09/2005 | US20050124550 Compounds that modulate the glucagon response and uses thereof |
| 06/09/2005 | US20050124547 Tau-conotoxin peptides |
| 06/09/2005 | US20050124543 Heterologous polypeptide of the TNF family |
| 06/09/2005 | US20050124542 Using aqueous solution of glucangon-like peptide and solvent; crystallization; isolation of crystals |
| 06/09/2005 | US20050124540 Antigens; induce immunology response; neutralizaton antibodies; prevent infections; diagnosis |
| 06/09/2005 | US20050124539 Ligand which binds to polypeptides; controlling eating disorders; screening process |
| 06/09/2005 | US20050124538 for prophylaxis, prevention, treatment or therapy of inflammatory conditions or allergic reactions in a mammal; binds bacterial lipopeptide |
| 06/09/2005 | US20050124537 Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein |
| 06/09/2005 | US20050124064 Antimicrobial polypeptides from pseudoplectania nigrella |
| 06/09/2005 | US20050124054 Novel proteins and methods for producing the proteins |
| 06/09/2005 | US20050124045 Comprising a peptide linker, and a human IgG Fc variant with amino acid mutations; encoded by DNA from a transfected cell line; culture purification; improved pharmacokinetics, extended serum half-life, side effects reduction; treating chronic anemia due to renal diseases |
| 06/09/2005 | US20050124044 Interleukin-21 analogs |
| 06/09/2005 | US20050124043 Chemotactic cytokine for use in diagnosis, prevention and treatment of tumors |
| 06/09/2005 | US20050124042 Method for expression of heterologous proteins in yeast |
| 06/09/2005 | US20050124037 Nucleic acid molecules encoding proteins which impart the adhesion of Neisseria cells to human cells |
| 06/09/2005 | US20050124015 Polypeptide mixture for use as diagnostic tool in detection of ehrlichia equi infection |
| 06/09/2005 | US20050124011 Screening tear fluids for presence of tumor marker protein; non-invasive cancer detection |
| 06/09/2005 | US20050124004 Histamine receptor h3 polynucleotides |
| 06/09/2005 | US20050123999 Dihydroouabain-like factor and diagnostic & therapeutic compositions and methods |
| 06/09/2005 | US20050123998 Nucleotide sequences coding gprotein coupled receptor for use in identifying modulator for prevention and treatment of asthma, inflammatory, heart land cardiovascular disorders |
| 06/09/2005 | US20050123997 Modified fVIII having reduced immunogenicity through mutagenesis of A2 and C2 epitopes |
| 06/09/2005 | US20050123994 Composition for protecting proteins degradation comprising small heat shock proteins (sHSPs) and method of two-dimensional gel electrophoresis using the sHSPs |
| 06/09/2005 | US20050123990 Membrane protein for use as tool in identifying modulator for treatment or prevention of inflammation, cell proliferative, neurological and gastrointestinal disorders |
| 06/09/2005 | US20050123982 Solute carrier transport protein peptide for use in treatment and prevention of nervous system and cell proliferative disorders |
| 06/09/2005 | US20050123978 Knockout mouse for the tumor suppressor gene ANX7 |
| 06/09/2005 | US20050123977 Using variation in tumor suppressor protein gene (p53) as diagnostic tool in detection and treatment of cell proliferative disorders |
| 06/09/2005 | US20050123972 Such as ligand binding and screening assays and signalling assays; chimeric chemokine receptor can also form a component of a chemokine receptor modulator design program |
| 06/09/2005 | US20050123969 Using homeobox and death-associated protein kinase (DAP-kinase) gene expression as diagnostic indicators of cell proliferative disorders of respiratory system |
| 06/09/2005 | US20050123967 Using high in normal-1(HIN-1) gene expression as diagnostic tool in detection of cell proliferative disorders |
| 06/09/2005 | US20050123966 Diagnostic and prognostic methods and compositions for seizure- and plasticity-related disorders |
| 06/09/2005 | US20050123964 G-protein coupled receptors high-throughput functional assay |
| 06/09/2005 | US20050123962 Regulated nucleic acids in pathogenesis of alzheimer's disease |
| 06/09/2005 | US20050123961 Human G-protein coupled receptors |
| 06/09/2005 | US20050123960 Secretory glaucoma protein (myocilin) for use as diagnostic and therapeutic tool in identifying modulators of vision loss |
| 06/09/2005 | US20050123955 Novel human thrombospondin-like proteins and polynucleotides encoding the same |
| 06/09/2005 | US20050123949 Transmembrane proteins for use in identifying modulator for treatment of inflammatory, splenic, bone, respiratory and cell proliferative disorders |
| 06/09/2005 | US20050123941 Expression vector comprising nucleotide sequences coding polypeptide associated with fructo-oligosaccharide proteins for use in prevention or treatment of infections, diarrheal, cell proliferative and immune system disorders |
| 06/09/2005 | US20050123922 Method for the selection of compounds useful for the treatment of huntington's disease |
| 06/09/2005 | US20050123920 Jade nucleic acids, proteins and uses thereof |
| 06/09/2005 | US20050123918 Mhc class I peptide epitopes from the human 5t4 tumor-associated antigen |
| 06/09/2005 | US20050123912 Nucleoprotein for use as tool in treatment, diagnosis and prevention of infection, cell proliferative, neurological, developmental, autoimmune and inflammatory disorders |
| 06/09/2005 | US20050123910 Nucleotide sequences coding prolyl oligopeptidase (DPP10) for use in identifying modulator which prevent and treat allergies, asthma, skin and inflammatory diseases |
| 06/09/2005 | US20050123909 Compositions and methods for treating cells having double minute dna |
| 06/09/2005 | US20050123902 Human papillomavirus inhibitors |
| 06/09/2005 | US20050123605 Anticancer agents; prevent forming blood vessels; removal blockage |
| 06/09/2005 | US20050123571 Modulation of apoptosis |
| 06/09/2005 | US20050123569 Nucleic acids encoding a house dust mite allergen Der p III, and uses therefor |
| 06/09/2005 | US20050123568 Chromatographic purification steps using unbuffered aqueous bases as eluent and subsequent neutralization; low side effect for specific immunotherapy of this pollen allergy; reduced immunoglobulin E binding with simultaneous retention of therapeutically relevant T-cell stimulation |
| 06/09/2005 | US20050123564 Production of viruses viral isolates and vaccines |
| 06/09/2005 | US20050123563 Lipoparticles comprising proteins, methods of making, and using the same |
| 06/09/2005 | US20050123562 Novel composition |
| 06/09/2005 | US20050123561 Recombinant Mycobacterium bovis bacille Calmette-Guérin (BCG) vaccine transformed with a vector that expresses an exogenous antigenic protein; vaccine used for initial antigen stimulation in immune induction by plural antigen stimulations; prevention of infectious diseases such as HIV |
| 06/09/2005 | US20050123558 Modifeid polypeptide |
| 06/09/2005 | US20050123557 AntiI-protozoal vaccine |
| 06/09/2005 | US20050123555 Alphavirus vectors and virosomes with modified HIV genes for use as vaccines |
| 06/09/2005 | US20050123554 derived from Ixodes scapularis; polypeptides designated 4D8, 4F8 and 4E6 |